|
[1]
|
Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 2011;364(16):1523 − 32. https://doi.org/10.1056/NEJMoa 1010095.Huang X, Ding S, Jiang X, Pang B, Zhang Q, Li C, et al. Detection of SFTS virus RNA and antibodies in severe fever with thrombocytopenia syndrome surveillance cases in endemic areas of China. BMC Infect Dis 2019;19476. https://doi.org/10.1186/s12879-019-4068-2.CrossRef
|
|
[2]
|
Huang XX, Ding SJ, Jiang XL, Pang B, Zhang QF, Li C, et al. Detection of SFTS virus RNA and antibodies in severe fever with thrombocytopenia syndrome surveillance cases in endemic areas of China. BMC Infect Dis 2019;19(1):476. https://doi.org/10.1186/s12879-019-4068-2CrossRef
|
|
[3]
|
Hu LF, Kong QX, Liu YY, Li JJ, Bian TT, Ma XJ, et al. Time course of severe fever with thrombocytopenia syndrome virus and antibodies in patients by long-term follow-up study, China. Front Microbiol 2021;12:744037. https://doi.org/10.3389/fmicb.2021.744037CrossRef
|
|
[4]
|
Li JC, Ding H, Wang G, Zhang S, Yang X, Wu YX, et al. Dynamics of neutralizing antibodies against severe fever with thrombocytopenia syndrome virus. Int J Infect Dis 2023;134:95 − 8. https://doi.org/10.1016/j.ijid.2023.05.018CrossRef
|
|
[5]
|
Chung H, Kim E, Kwon B, Cho YG, Bae S, Jung J, et al. Kinetics of glycoprotein-specific antibody response in patients with severe fever with thrombocytopenia syndrome. Viruses 2022;14(2):256. https://doi.org/10.3390/v14020256CrossRef
|
|
[6]
|
Wang G, Chang HY, Jia B, Liu Y, Huang R, Wu WH, et al. Nucleocapsid protein-specific IgM antibody responses in the disease progression of severe fever with thrombocytopenia syndrome. Ticks Tick Borne Dis 2019;10(3):639 − 46. https://doi.org/10.1016/j.ttbdis.2019.02.003CrossRef
|
|
[7]
|
Song PX, Zheng N, Liu Y, Tian C, Wu XL, Ma XH, et al. Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection. Nat Commun 2018;9(1):3328. https://doi.org/10.1038/s41467-018-05746-9CrossRef
|
|
[8]
|
Li JC, Zhao J, Li H, Fang LQ, Liu W. Epidemiology, clinical characteristics, and treatment of severe fever with thrombocytopenia syndrome. Infect Med. 2022;1:40 − 9 https://doi.org/10.1016/j.imj.2021.10.001CrossRef
|
|
[9]
|
Lu QB, Cui N, Hu JG, Chen WW, Xu W, Li H, et al. Characterization of immunological responses in patients with severe fever with thrombocytopenia syndrome: a cohort study in China. Vaccine 2015;33(10):1250 − 5. https://doi.org/10.1016/j.vaccine.2015.01.051CrossRef
|
|
[10]
|
Qi R, Huang YT, Yu XJ. Persistence and gender differences in protection against severe fever with thrombocytopaenia syndrome virus with natural infection: a 4-year follow-up and mathematical prediction study. Epidemiol Infect 2019;147:e78. https://doi.org/10.1017/S1469440918003643CrossRef
|